Identification and characterization of IFI30 as a glioblastoma specific promoter for glioma gene therapy
Master's
Saved in:
Main Author: | MADHUMITHA RENGASAMY |
---|---|
Other Authors: | BIOLOGICAL SCIENCES |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/16878 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
COMPARISON OF CYTOSINE DEAMINASE/5-FLUOROCYTOSINE VERSUS HERPES SIMPLEX VIRUS THYMIDINE KINASE/GANCICLOVIR ENZYME/PRODRUG SYSTEMS IN GLIOBLASTOMA GENE THERAPY.
by: YE KAI
Published: (2012) -
Baculovirus-mediated gene delivery for glioma therapy
by: LI FENG
Published: (2010) -
Antiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate
by: Guo, H., et al.
Published: (2014) -
CANCER IMMUNOGENE THERAPY USING VIRAL VECTORS ENCODING CYTOKINES AND CHIMERIC ANTIGEN RECEPTORS
by: ANG WEI XIA
Published: (2018) -
IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study
by: Shojaei, M, et al.
Published: (2023)